Tapentadol is partially metabolized via the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that greatly enhance or repress the exercise/expression of one or more of these enzymes, in addition to with substrates of such enzymes (as a consequence of Competitors for that enzyme); https://harrisonf332wnd1.wikifordummies.com/user